HER2-positive Breast Cancer Registry

Part of paid clinical trials in Overland Park, Kansas.

Sponsor
Priyanka Sharma
Study ID
NCT06603597
Status
Recruiting
Apply to this trial

Conditions

  • HER2 + Breast Cancer

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

The goal of this observational study is to better understand links between patient or tumor characteristics and outcomes in HER2-positive breast cancer.

Key Dates

First listed
Sep 19, 2024
Start date
Sep 27, 2024
Status verified
Sep 2025
Primary completion
Oct 31, 2044
Completion
Oct 31, 2044

Study Design

Enrollment
1,000 participants (estimated)

Arms

  • Arm: HER2-positive breast cancer
    Patients with stage I-IV HER2-positive breast cancer

Primary Outcome Measure

Overall survival rate [ Time Frame: From diagnosis to 5 years after diagnosis ]

Central Contacts

Locations (6)

FacilityCityStateZIPSite coordinators
KUCC - Indian CreekOverland ParkKansas66211-
KUCC - Overland ParkOverland ParkKansas66215-
KUCC - BriarcliffWestwoodKansas66205-
KUCC - OlatheWestwoodKansas66205-
The University of Kansas Cancer CenterWestwoodKansas66205
Study Coordinator
[email protected]
913-588-6079
KUCC - Lee's SummitLee's SummitMissouri64064-

Find similar trials in Overland Park, KS

By research site
KUCC - Indian Creek· Overland Park, KSKUCC - Overland Park· Overland Park, KSKUCC - Briarcliff· Westwood, KSKUCC - Olathe· Westwood, KSThe University of Kansas Cancer Center· Westwood, KSKUCC - Lee's Summit· Lee's Summit, MO

Related Studies